Latest Oncologists Stories
Company Provides Widest Variety of Actionable Next-Gen Cancer Profiles FT. MYERS, Fla., July 11, 2014 /PRNewswire/ -- NeoGenomics, Inc.
Allegheny Health Network, Pittsburgh, and Johns Hopkins Medicine today announced that a definitive agreement has been signed by the two organizations that establishes a five-year formal collaboration
Former Genentech executive to lead Moderna's first venture company, focused exclusively in novel biology for oncology drug development CAMBRIDGE, Mass., July 1, 2014 /PRNewswire/ --
OWINGS MILLS, Md., June 27, 2014 /PRNewswire-USNewswire/ -- In ongoing support of prostate cancer research, Sanford Siegel, M.D., President and CEO of
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
The Pancreatic Cancer Action Network, Rising Tide Foundation for Clinical Research, and Gateway for Cancer Research Award More Than $1.2 Million in Grants MANHATTAN BEACH, Calif.,
ANN ARBOR, Mich., June 4, 2014 /PRNewswire-USNewswire/ -- A physician-scientist who developed a personalized immunotherapy for leukemia using patients' own T cells is the recipient of the 2014
Phase 2 study data presented at the 50th annual meeting of the American Society of Clinical Oncology HORSHAM, Pa., June 2, 2014 /PRNewswire/ -- Abiraterone acetate (ZYTIGA(®)) plus
New Chief Medical Officer Brings Wealth of Experience in Innovative Therapies in Oncology SANTA MONICA, Calif., June 2, 2014 /PRNewswire/ -- Kite Pharma, Inc., a clinical-stage biopharmaceutical
Appointees join Caris' distinguished clinical and scientific team to accelerate the development and commercialization of innovative precision medicine technologies IRVING,
- A trick or prank.